Pure Global

Phase I Clinical Trial of Inactivated Rotavirus Vaccine in a Population Aged 6 Weeks-49 Years Old - Trial NCT06350058

Access comprehensive clinical trial information for NCT06350058 through Pure Global AI's free database. This Phase 1 trial is sponsored by Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd and is currently Recruitment Completed. The study focuses on Healthy Volunteers. Target enrollment is 375 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06350058
Phase 1
Recruitment Completed
biological
Trial Details
ClinicalTrials.gov • NCT06350058
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Phase I Clinical Trial of Inactivated Rotavirus Vaccine in a Population Aged 6 Weeks-49 Years Old
A Phase I, Single Center, Randomized, Double-blind, Placebo-controlled, Dose Escalation Study to Evalution the Safety, Tolerability of Inactivated Rotavirus Vaccine in a Population Aged 6 Weeks-49 Years Old

Study Focus

Healthy Volunteers

Inactivated rotavirus vaccine (low dose)

Interventional

biological

Sponsor & Location

Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd

Shijiangzhuang, China

Timeline & Enrollment

Phase 1

Aug 03, 2021

Oct 31, 2024

375 participants

Primary Outcome

Incidence rate of AE,Incidence rate of SAE

Summary

The research objective is to evaluate the safety and tolerability of the inactivated
 rotavirus vaccine and explore its preliminary immunogenicity.

ICD-10 Classifications

Healthy person accompanying sick person
Routine general health check-up of armed forces
Routine general health check-up of sports teams
Routine general health check-up of inhabitants of institutions

Data Source

ClinicalTrials.gov

NCT06350058

Non-Device Trial